Skip to main content
. 1999 Oct;37(10):3291–3295. doi: 10.1128/jcm.37.10.3291-3295.1999

TABLE 1.

Age-specific prevalence of HGV and anti-HEV in healthy Bolivian individuals

Virus or antibody No. (%) of individuals with virus or antibody who were aged (yr):
≤19 (n = 34) 20–39 (n = 279) ≥40 (n = 57)
HGV RNA 3 (8.8) 42 (15.1) 3 (5.3)
Anti-HEV (IgG) 7 (20.6) 50 (17.9) 10 (17.5)